BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24760754)

  • 1. Enhanced angiogenesis and increased cardiac perfusion after myocardial infarction in protein tyrosine phosphatase 1B-deficient mice.
    Besnier M; Galaup A; Nicol L; Henry JP; Coquerel D; Gueret A; Mulder P; Brakenhielm E; Thuillez C; Germain S; Richard V; Ouvrard-Pascaud A
    FASEB J; 2014 Aug; 28(8):3351-61. PubMed ID: 24760754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in mice.
    Besnier M; Coquerel D; Favre J; Dumesnil A; Guerrot D; Remy-Jouet I; Mulder P; Djerada Z; Tamion F; Richard V; Ouvrard-Pascaud A
    Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1279-H1288. PubMed ID: 29569957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice.
    Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K
    Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Vascular Endothelial Protection Reduces Cardiac Dysfunction in Chronic Heart Failure.
    Maupoint J; Besnier M; Gomez E; Bouhzam N; Henry JP; Boyer O; Nicol L; Mulder P; Martinet J; Richard V
    Circ Heart Fail; 2016 Apr; 9(4):e002895. PubMed ID: 27059805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B.
    Gomez E; Vercauteren M; Kurtz B; Ouvrard-Pascaud A; Mulder P; Henry JP; Besnier M; Waget A; Hooft Van Huijsduijnen R; Tremblay ML; Burcelin R; Thuillez C; Richard V
    J Mol Cell Cardiol; 2012 Jun; 52(6):1257-64. PubMed ID: 22446161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.
    Coquerel D; Neviere R; Delile E; Mulder P; Marechal X; Montaigne D; Renet S; Remy-Jouet I; Gomez E; Henry JP; do Rego JC; Richard V; Tamion F
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1032-44. PubMed ID: 24578383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.
    Nakamura Y; Patrushev N; Inomata H; Mehta D; Urao N; Kim HW; Razvi M; Kini V; Mahadev K; Goldstein BJ; McKinney R; Fukai T; Ushio-Fukai M
    Circ Res; 2008 May; 102(10):1182-91. PubMed ID: 18451337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTP1b is a physiologic regulator of vascular endothelial growth factor signaling in endothelial cells.
    Lanahan AA; Lech D; Dubrac A; Zhang J; Zhuang ZW; Eichmann A; Simons M
    Circulation; 2014 Sep; 130(11):902-9. PubMed ID: 24982127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
    Westenbrink BD; Ruifrok WP; Voors AA; Tilton RG; van Veldhuisen DJ; Schoemaker RG; van Gilst WH; de Boer RA
    Cardiovasc Res; 2010 Jul; 87(1):30-9. PubMed ID: 20139114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein tyrosine phosphatase 1B impairs diabetic wound healing through vascular endothelial growth factor receptor 2 dephosphorylation.
    Zhang J; Li L; Li J; Liu Y; Zhang CY; Zhang Y; Zen K
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):163-74. PubMed ID: 25395617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
    Westenbrink BD; Lipsic E; van der Meer P; van der Harst P; Oeseburg H; Du Marchie Sarvaas GJ; Koster J; Voors AA; van Veldhuisen DJ; van Gilst WH; Schoemaker RG
    Eur Heart J; 2007 Aug; 28(16):2018-27. PubMed ID: 17576662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein Phosphotyrosine Phosphatase 1B (PTP1B) in Calpain-dependent Feedback Regulation of Vascular Endothelial Growth Factor Receptor (VEGFR2) in Endothelial Cells: IMPLICATIONS IN VEGF-DEPENDENT ANGIOGENESIS AND DIABETIC WOUND HEALING.
    Zhang Y; Li Q; Youn JY; Cai H
    J Biol Chem; 2017 Jan; 292(2):407-416. PubMed ID: 27872190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice prevents cardiac dysfunction and remodeling after myocardial infarction.
    Morimoto H; Takahashi M; Izawa A; Ise H; Hongo M; Kolattukudy PE; Ikeda U
    Circ Res; 2006 Oct; 99(8):891-9. PubMed ID: 16990567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase.
    Landmesser U; Engberding N; Bahlmann FH; Schaefer A; Wiencke A; Heineke A; Spiekermann S; Hilfiker-Kleiner D; Templin C; Kotlarz D; Mueller M; Fuchs M; Hornig B; Haller H; Drexler H
    Circulation; 2004 Oct; 110(14):1933-9. PubMed ID: 15466656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.
    Kinugasa M; Amano H; Satomi-Kobayashi S; Nakayama K; Miyata M; Kubo Y; Nagamatsu Y; Kurogane Y; Kureha F; Yamana S; Hirata K; Miyoshi J; Takai Y; Rikitake Y
    Circ Res; 2012 Mar; 110(5):716-26. PubMed ID: 22282193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of Protein Tyrosine Phosphatase 1B (PTP1B) Enhances Endothelial Cyclooxygenase 2 Expression and Protects Mice from Type 1 Diabetes-Induced Endothelial Dysfunction.
    Herren DJ; Norman JB; Anderson R; Tremblay ML; Huby AC; Belin de Chantemèle EJ
    PLoS One; 2015; 10(5):e0126866. PubMed ID: 25974252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baroreflex deficiency hampers angiogenesis after myocardial infarction via acetylcholine-α7-nicotinic ACh receptor in rats.
    Yu JG; Song SW; Shu H; Fan SJ; Liu AJ; Liu C; Guo W; Guo JM; Miao CY; Su DF
    Eur Heart J; 2013 Aug; 34(30):2412-20. PubMed ID: 21849351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Intensity Pulsed Ultrasound Enhances Angiogenesis and Ameliorates Left Ventricular Dysfunction in a Mouse Model of Acute Myocardial Infarction.
    Shindo T; Ito K; Ogata T; Hatanaka K; Kurosawa R; Eguchi K; Kagaya Y; Hanawa K; Aizawa K; Shiroto T; Kasukabe S; Miyata S; Taki H; Hasegawa H; Kanai H; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1220-9. PubMed ID: 27079882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.
    Kobayashi H; Yasuda S; Bao N; Iwasa M; Kawamura I; Yamada Y; Yamaki T; Sumi S; Ushikoshi H; Nishigaki K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):510-9. PubMed ID: 19755919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.